Head-to-head · Cost-Efficiency Index
Gimme Care vs Piper
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Gimme Care
Budget-conscious shoppers who want both molecules disclosed, nationwide access, and pharmacy verification without a premium.
Visit Gimme CarePiper
Nationwide shoppers who want both molecules disclosed at fair prices and will do their own diligence on the pharmacy.
Visit PiperThe verdict
Gimme Care takes it, leading the Cost-Efficiency Index 87 to 82. Low, fully-disclosed pricing on both molecules nationwide from a LegitScript-verified operator — strong dollar-for-dollar value. Piper still earns a B− — Nationwide shoppers who want both molecules disclosed at fair prices and will do their own diligence on the pharmacy.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Gimme Care.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Gimme Care | Piper |
|---|---|---|
| Cost-Efficiency Index | 87/100 | 82/100 |
| Semaglutide / mo | $130/mo | $135/mo |
| Tirzepatide / mo | $163/mo | $199/mo |
| Semaglutide / yr (modeled) | $1,560 | $1,620 |
| Tirzepatide / yr (modeled) | $1,956 | $2,388 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank on the board | #7 | #22 |
Gimme Care
87/100Where the value is
- Low published prices on both molecules — $130 semaglutide / $163 tirzepatide
- Nationwide all-50 availability with both molecules disclosed
- LegitScript-certified pharmacy behind the program
The tradeoffs
- Compounded only — no brand-name or oral options
- Lower-profile brand with a thinner public track record
Piper
82/100Where the value is
- Both molecules disclosed — $135 semaglutide / $199 tirzepatide — for clean cost modeling
- Nationwide all-50 access with predictable flat pricing
- Straightforward to model for a full year
The tradeoffs
- Not LegitScript-certified, so pharmacy oversight is harder to verify
- Compounded only — no brand-name or oral route
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.